(19)
(11) EP 2 600 895 A1

(12)

(43) Date of publication:
12.06.2013 Bulletin 2013/24

(21) Application number: 11741731.1

(22) Date of filing: 02.08.2011
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
C07K 16/28(2006.01)
(86) International application number:
PCT/US2011/046205
(87) International publication number:
WO 2012/018771 (09.02.2012 Gazette 2012/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 07.02.2011 US 201161440162 P
03.08.2010 US 370403 P

(71) Applicant: Hoffmann-La Roche AG
4070 Basel (CH)

(72) Inventors:
  • DORNAN, David
    California 94080 (US)
  • DUCHATEAU-NGUYEN, Guillemette
    CH-4070 Basel (CH)
  • NGUYEN, Tri Quang
    CH-4070 Basel (CH)
  • PALERMO, Giuseppe
    CH-4070 Basel (CH)
  • WEISSER, Martin
    CH-4070 Basel (CH)
  • YEH, Ru-Fang
    California 94080 (US)

(74) Representative: Klein, Thomas 
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel
4070 Basel (CH)

   


(54) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) BIOMARKERS